Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica
Clinical trial NCT02899026 · WITHDRAWN
Trial details
- NCT number
- NCT02899026
- Sponsor
- GlaxoSmithKline
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2020-08-26
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.